Attributes | Values |
---|
rdf:type
| |
rdfs:seeAlso
| |
Description
| - Recently obesity has become a worldwide problém. It has become the most frequent metabolic disease as a result of life conditions and lifestyle changes which have resulted in a positive energetic balance The endpoint of the trial was a targeted reduction of excessive body weight in 99 individuals with BMI over 30 or 27 kg/m2 respectively. Three-month weight reduction therapy was based on the restriction of energy intake and pharmacotherapy by Sibutramine hydrochloride monohydrate (Sibutramine) 10 mg/person/day. Following the three-month therapy, weight loss, decrease of body fat, lower waist circumference, improved lipid profile and decreased of systolic as well as diastolic blood pressure were demonstrated. There was a statistically insignificant increase of heart rate during the study. Sibutramine therapy of obesity had no adverse effects that would result in the termination of therapy.
- Recently obesity has become a worldwide problém. It has become the most frequent metabolic disease as a result of life conditions and lifestyle changes which have resulted in a positive energetic balance The endpoint of the trial was a targeted reduction of excessive body weight in 99 individuals with BMI over 30 or 27 kg/m2 respectively. Three-month weight reduction therapy was based on the restriction of energy intake and pharmacotherapy by Sibutramine hydrochloride monohydrate (Sibutramine) 10 mg/person/day. Following the three-month therapy, weight loss, decrease of body fat, lower waist circumference, improved lipid profile and decreased of systolic as well as diastolic blood pressure were demonstrated. There was a statistically insignificant increase of heart rate during the study. Sibutramine therapy of obesity had no adverse effects that would result in the termination of therapy. (en)
|
Title
| - Effects of The Sibutramine Therapy on Selected Biochemical Parameters in Obese Patients
- Effects of The Sibutramine Therapy on Selected Biochemical Parameters in Obese Patients (en)
|
skos:prefLabel
| - Effects of The Sibutramine Therapy on Selected Biochemical Parameters in Obese Patients
- Effects of The Sibutramine Therapy on Selected Biochemical Parameters in Obese Patients (en)
|
skos:notation
| - RIV/68407700:21230/14:00210910!RIV15-MSM-21230___
|
http://linked.open...avai/riv/aktivita
| |
http://linked.open...avai/riv/aktivity
| |
http://linked.open...iv/cisloPeriodika
| |
http://linked.open...vai/riv/dodaniDat
| |
http://linked.open...aciTvurceVysledku
| |
http://linked.open.../riv/druhVysledku
| |
http://linked.open...iv/duvernostUdaju
| |
http://linked.open...titaPredkladatele
| |
http://linked.open...dnocenehoVysledku
| |
http://linked.open...ai/riv/idVysledku
| - RIV/68407700:21230/14:00210910
|
http://linked.open...riv/jazykVysledku
| |
http://linked.open.../riv/klicovaSlova
| - Obesity; Sibutramine Hydrochloride Monohydrate; OMRON Analyzer; Energy Intake; Non-Communicable Widespread Diseases; BMI (en)
|
http://linked.open.../riv/klicoveSlovo
| |
http://linked.open...odStatuVydavatele
| |
http://linked.open...ontrolniKodProRIV
| |
http://linked.open...i/riv/nazevZdroje
| - Indian Journal of Applied Research
|
http://linked.open...in/vavai/riv/obor
| |
http://linked.open...ichTvurcuVysledku
| |
http://linked.open...cetTvurcuVysledku
| |
http://linked.open...UplatneniVysledku
| |
http://linked.open...v/svazekPeriodika
| |
http://linked.open...iv/tvurceVysledku
| - Hlúbik, Jan
- Hlúbik, P.
- Střítecká, H.
|
issn
| |
number of pages
| |
http://localhost/t...ganizacniJednotka
| |